CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, announced today organizational changes to the executive leadership team to position the ...
Foundation Medicine, Inc., a global, patient-focused precision medicine company, and SWOG Clinical Trials Partnerships (SWOG CTP) today announced a strategic partnership to advance biomarker-driven ...
Whole Genome Sequencing (WGS) test now available through Foundation Medicine’s FlexOMx Lab™ to support biomarker discovery and drug development across cardiometabolic, immunologic and neurologic ...
Foundation Medicine tallied another nod from the FDA for one of its genomic profiling tests that searches for specific ...
LYNPARZA was approved based on positive results from the PROfound study for which Foundation Medicine served as the Next-Generation Sequencing (NGS) partner Prostate cancer is the second most common ...
Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced plans to launch advanced digital solutions to equip healthcare providers with personalized patient ...
Foundation Medicine and Epic struck a deal to integrate comprehensive genomic profiling within Epic's electronic health records (EHRs), allowing for providers to order and review genomic profiling ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. today announced the appointment of Cindy Perettie as chief executive officer, effective February 4, 2019. Ms. Perettie will succeed Troy ...
Roche just made another big bet on cancer data. On Tuesday, the Swiss pharma giant acquired the rest of Foundation Medicine, a company that sequences the genetics of a person's tumor, for $2.4 billion ...
WS Development has scored the largest life science development in Boston since Vertex Pharmaceuticals' landmark Seaport deal in 2011. Cambridge-based Foundation Medicine has leased 580K SF of office ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
The company's being acquired by long-time partner Roche Holdings. A stand-still provision that's kept Roche Holdings from acquiring or selling its Foundation Medicine shares expired earlier this year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results